This page shows the Summary of Product Characteristics (SPC) and patient information leaflet (PIL) for the product.
Before a medicine can be sold in the UK, a number of licences are essential. Products with a UK marketing authorisation have a licence number in the format 'PL 12345/0001'. The first two characters are always the letters 'PL'. The product licence number can be found on the packaging of the product. You can identify the product in the list below using the PL number in the links below.
Please read the following information and tick the box to proceed to view the product information in pdf format.
I understand that this information is a copy of the Summary of Product Characteristics and patient information leaflet for a medicine, which outline the conditions under which the medicine should be used and information on its known safety.
I understand that this information may be updated several times within its shelf life, and that there could be differences between the version of the information shown here and other information in the public domain.
I understand that the MHRA is unable to offer medical advice and that if a patient has any questions about a medicine they are taking they should contact their doctor or pharmacist. Patients should not stop taking any prescribed medicines without first speaking to a healthcare professional. Suspected adverse reactions to a medicine can be reported to us on a Yellow Card
I understand that the MHRA has used its best endeavours in publishing this information, but accept that the information may not be the most up to date version for this product.
To view details for SUNVENIZ XL 75 MG PROLONGED-RELEASE TABLETS, please read and accept the disclaimer or go back to product listing for VENLAFAXINE HYDROCHLORIDE.